Logo image
Back
Efficacy of Surgical-Site, Multimodal Drug Injection Following Operative Management of Femoral Fractures: A Randomized Controlled Trial
Journal article   Peer reviewed

Efficacy of Surgical-Site, Multimodal Drug Injection Following Operative Management of Femoral Fractures: A Randomized Controlled Trial

Daniel Koehler, J Lawrence Marsh, Matthew Karam, Catherine Fruehling and Michael Willey
Journal of bone and joint surgery. American volume, Vol.99(6), pp.512-519
03/15/2017
DOI: 10.2106/JBJS.16.00733
PMID: 28291185

View Online

Abstract

Multimodal analgesia inclusive of periarticular injection with a local anesthetic agent has been rapidly assimilated, with demonstrated safety and efficacy, into the care of patients undergoing elective lower-extremity arthroplasty. The present study was performed to evaluate the efficacy and safety of a surgical-site, multimodal drug injection for postoperative pain control following operative management of femoral fractures. There were 102 patients undergoing operative intervention (plate fixation, intramedullary device, or arthroplasty) for a broad range of femoral fracture patterns who were prospectively randomized either to receive an intraoperative, surgical-site injection into the superficial and deep tissues containing ropivacaine, epinephrine, and morphine or to receive no injection. Visual analog scale (VAS) scores were recorded at regular intervals as the primary outcome measure. Narcotic consumption and medication-related side effects were also monitored. The injection group demonstrated significantly lower VAS scores (p < 0.05) than the control cohort in the recovery room and at the 4, 8, and 12-hour postoperative time points. The median score (and interquartile range) was 1.6 (0 to 4.0) for the injection group and 3.2 (1.3 to 5.7) for the control group immediately postoperatively, 1.0 (0 to 3.0) for the injection group and 5.0 (2.0 to 7.0) for the control group at 4 hours, 2.0 (0 to 4.0) for the injection group and 5.0 (2.0 to 6.8) for the control group at 8 hours, and 3.5 (0 to 5.0) for the injection group and 5.0 (2.0 to 8.0) for the control group at 12 hours. Additionally, narcotic consumption was significantly lower (p = 0.007) in the injection group (5.0 mg [1.3 to 8.0 mg]) compared with the control group (9.7 mg [3.9 to 15.6 mg]) over the first 8 hours following the surgical procedure. No cardiac or central nervous system toxicity was observed secondary to infiltration of the local anesthetic. Surgical-site injection with a multimodal analgesic cocktail provides improved pain control and reduces narcotic utilization over the first postoperative day, with no observed adverse effects attributable to the local injection, across a diverse orthopaedic trauma population undergoing operative intervention for femoral fractures. Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.
 Pain, Postoperative - etiology Analgesics - therapeutic use Fracture Fixation - adverse effects Analgesia, Patient-Controlled Pain, Postoperative - drug therapy Analgesia - methods Humans Middle Aged Male Treatment Outcome Amides - therapeutic use Bone Plates Arthroplasty - adverse effects Epinephrine - therapeutic use Femoral Fractures - surgery Injections, Intra-Articular Aged, 80 and over Adult Female Aged Pain Measurement Morphine - therapeutic use

Details

Metrics

30 Record Views
32 Times Cited - Web of Science
Logo image